Highlights | Eli Lilly beat estimates and raised full-year earnings guidance, sending a surge of more than 10% in its share price in pre-market trading
Currency:USDAug 8, 2024
Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
Revenue | 9.97B | 11.30B | +1.34B |
Beat Est. | +19.92% | +35.98% | +13.40% |
EPS | 2.72 | 3.28 | +0.56 |
Beat Est. | +39.43% | +68.21% | +20.64% |
Oct 2, 2024
Revenue
EPS
EBIT
Revenue is based on 15 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Unlock Free Earnings Estimates
Read more
No Data
No Data